The clinical spectrum of type IV collagen mutations

HH Lemmink, CH Schröder, LAH Monnens… - Human …, 1997 - Wiley Online Library
Clinical manifestations of type IV collagen mutations can vary from the severe, clinically and
genetically heterogeneous renal disorder, Alport syndrome, to autosomal dominant familial …

Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis

RA De Moor, ACG Egberts, CH Schröder - European journal of pediatrics, 1999 - Springer
Biliary pseudolithiasis has been reported in patients who received ceftriaxone therapy. In
addition to biliary sludge formation occasional reports of ceftriaxone-induced nephrolithiasis …

Identification of mutations in the α3 (IV) and α4 (IV) collagen genes in autosomal recessive Alport syndrome

T Mochizuki, HH Lemmink, M Mariyama, C Antignac… - Nature …, 1994 - nature.com
Alport syndrome (AS) is an hereditary disease of basement membranes characterized by
progressive renal failure and deafness. Changes in the glomerular basement membrane (GBM…

Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell

CT Bock, P Schranz, CH Schröder, H Zentgraf - Virus genes, 1994 - Springer
Hepatitis B virus (HBV) nucleoprotein complexes were isolated from nuclei of the human
hepatoblastoma cell line HepG2.2.15. Under conditions of physiological ionic strength, the …

Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion

HJ Hacker, K Deres, M Mildenberger… - Biochemical …, 2003 - Elsevier
Recently, heteroarylpyrimidines (HAP) have been identified as potent inhibitors of capsid
maturation. Here we discuss the HAP mode of action comparing the aggregation phenotype of …

Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas

Q Su, CH Schröder, WJ Hofmann, G Otto… - Hepatology, 1998 - journals.lww.com
Transactivation of cellular genes and functional inactivation of p53 by the hepatitis B virus (HBV)
X gene-encoded protein (HBx) are proposed as alternative mechanisms for induction of …

Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndrome

HH Lemmink, T MochlzukJ… - Human molecular …, 1994 - academic.oup.com
A group of 22 unrelated patients with sporadic or non-X-llnked Alport syndrome were screened
for mutations In the non-collagenous domain of the type IV collagen a3 (COL4A3) chain …

Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids

K Deres, CH Schroder, A Paessens, S Goldmann… - Science, 2003 - science.org
Chronic hepatitis B virus (HBV) infection is a major cause of liver disease. Only interferon-α
and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for …

Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.

HH Lemmink, WN Nillesen, T Mochizuki… - The Journal of …, 1996 - Am Soc Clin Investig
Benign familial hematuria (BFH) is characterized by autosomal dominant inheritance, thinning
of the glomerular basement membrane (GBM) and normal renal function. It is frequent in …

[HTML][HTML] Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation

FTL Van Der Loop, L Heidet, EDJ Timmer… - Kidney international, 2000 - Elsevier
Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Background
Alport syndrome (AS) is a clinically and genetically heterogeneous renal disorder, …